Paediatric Hematologic Research Group
21 – 30 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
(
- Contribution to journal › Article
- 2011
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Delivery of a severe haemophilia foetus - vaginal delivery
(
- Contribution to journal › Published meeting abstract